Scilex Holding (SCLXW) Enterprise Value Growth (1y) (2021 - 2026)

Scilex Holding (SCLXW) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,484.90%
Dec 31, 2025 -362.29%
Sep 30, 2025 -4,683.12%
Jun 30, 2025 40.48%
Mar 31, 2025 -219.03%
Dec 31, 2024 16.55%
Sep 30, 2024 96.15%
Jun 30, 2024 79.81%
Mar 31, 2024 64.35%
Dec 31, 2023 -79.53%
Sep 30, 2023 -2,760.33%
Jun 30, 2023 75.98%
Mar 31, 2023 96.37%
Dec 31, 2022 98.48%
Sep 30, 2022 39.54%
Jun 30, 2022 -55,034.43%
Mar 31, 2022 -44,538.51%
Dec 31, 2021 -471,037.42%
Sep 30, 2021 -46.63%